GB807781A - Plasma fraction and standard plasma preparation and method of preparing same - Google Patents
Plasma fraction and standard plasma preparation and method of preparing sameInfo
- Publication number
- GB807781A GB807781A GB13545/55A GB1354555A GB807781A GB 807781 A GB807781 A GB 807781A GB 13545/55 A GB13545/55 A GB 13545/55A GB 1354555 A GB1354555 A GB 1354555A GB 807781 A GB807781 A GB 807781A
- Authority
- GB
- United Kingdom
- Prior art keywords
- plasma
- per cent
- sodium
- solution
- bovine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6432—Coagulation factor Xa (3.4.21.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21006—Coagulation factor Xa (3.4.21.6)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A plasma fraction capable of increasing the activity of thromboplastic material having a prothrombin time of more than 9 seconds is prepared at a low temperature, e.g. - 5 DEG to 5 DEG C., by adding 3 to 5 volumes of a 15 to 30 per cent by volume aqueous solution of methanol, ethanol or a mixture thereof, e.g. at - 5 DEG to - 10 DEG C., at a pH of 4 to 5, to prothrombin-free horse, bovine, human or rabbit plasma, e.g. at 5 DEG to 0 DEG C., stirring and centrifuging the mixture and adding to the separated residue, e.g. at 0 DEG to - 5 DEG C., 3 to 5 volumes of a 5 to 20 per cent aqueous solution of methanol, ethanol or a mixture thereof, e.g. at 0 DEG to - 5 DEG C., at a pH of 6 to 8, containing 4 to 6 per cent by weight of an alkali metal salt of an amino acid having not more than 6 carbon atoms, e.g. alumina, glycine, proline, serine, stirring and centrifuging the mixture, e.g. at 0 DEG to - 5 DEG C., dialyzing the filtered supernatant against distilled water, e.g. at 1 DEG to 5 DEG C., and lyophilizing the supernatant. A standard plasma preparation for use in the determination of the prothrombin time of thromboplastic material is prepared by dissolving 2 to 10 mg. of the plasma fraction per mol. of oxalated bovine plasma. The prothrombin free plasma may be prepared by centrifuging a solution of the plasma in a heparin sodium solution which has been slurried with 2 to 5 per cent barium sulphate. The oxalated bovine plasma is prepared by centrifuging a solution of bovine blood containing 10 per cent by volume of 0.1 molar sodium oxalate solution. The oxalated bovine plasma may be diluted with 0.85 per cent aqueous sodium chloride solution such that the plasma is present in an amount of 60 to 90 per cent by volume of the diluted plasma. The pH may be adjusted by addition of an alkali metal hydroxide, and buffered using a sodium acetate-acetic acid, sodium succinate-succinic acid, sodium acid phthalate-phthalic acid, mono- or di-sodium phthalate buffer. Specification 807,782 is referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US807781XA | 1954-05-27 | 1954-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB807781A true GB807781A (en) | 1959-01-21 |
Family
ID=22159560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB13545/55A Expired GB807781A (en) | 1954-05-27 | 1955-05-10 | Plasma fraction and standard plasma preparation and method of preparing same |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB807781A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11604026B2 (en) | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
US11634257B2 (en) | 2017-10-09 | 2023-04-25 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
-
1955
- 1955-05-10 GB GB13545/55A patent/GB807781A/en not_active Expired
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11634257B2 (en) | 2017-10-09 | 2023-04-25 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
US11604026B2 (en) | 2019-03-14 | 2023-03-14 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
US11609042B2 (en) | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
US11609043B2 (en) | 2019-03-14 | 2023-03-21 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
US11740019B2 (en) | 2019-03-14 | 2023-08-29 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
US11747082B2 (en) | 2019-03-14 | 2023-09-05 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
US11815311B2 (en) | 2019-03-14 | 2023-11-14 | Terumo Bct Biotechnologies, Llc | Lyophilization container fill fixture, system and method of use |
US11994343B2 (en) | 2019-03-14 | 2024-05-28 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kimberg et al. | Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins | |
ES444558A1 (en) | Production of long acting insulin preparations | |
GB807781A (en) | Plasma fraction and standard plasma preparation and method of preparing same | |
GB824908A (en) | Improvements in or relating to triazine derivatives | |
GB1372812A (en) | Cerebrospinal fluid control standard | |
GB1491816A (en) | Urokinase production | |
GB748024A (en) | Improved therapeutic preparations of iron | |
GB807782A (en) | Thromboplastin and thromboplastic compositions and method of preparation thereof | |
GB1046523A (en) | New preparations with adrenocorticotropic hormone activity and the manufacture thereof | |
US2574889A (en) | Methylated gelatin-insulin preparation | |
Fisher et al. | The effect of various substances on the action of insulin | |
GB705343A (en) | Improvements in or relating to aqueous suspensions of procaine penicillin | |
GB889769A (en) | Slowly acting insulin preparation in crystalline form | |
GB901675A (en) | Process for improving the storage qualities of conserved whole-blood | |
US2364579A (en) | Hog cholera vaccine | |
SU105567A1 (en) | Protein plasma substitution solution | |
Schmoyer et al. | Cystic fibrosis: effect of media from cultured cystic fibrosis fibroblasts on ATPase activity | |
GB691501A (en) | Preparation of hyaluronidase | |
GB816592A (en) | A method for the preparation of stable magnesium solutions of high concentration | |
GB768639A (en) | Method for ensilage of grass and green fodder | |
GB1498295A (en) | Treatment of dehydration in veterinary medicine | |
GB887012A (en) | Process for the preparation of 18ª--glycyrrhetinic acid | |
GB824483A (en) | Improvements in or relating to anti-haemophilic globulin | |
GB951591A (en) | Stabilised reagent for transaminase determination | |
GB859609A (en) | Improvements in or relating to lyophilized protein hydrolysates |